Affimed IPO Info
Company Name: Affimed
Stock Symbol: AFMD
Exchange: NASDAQ
Status: Priced
IPO Date: 9/12/2014
IPO Price:
7.00 (
-11.43%)
Underwriters
Jefferies, Leerink Partners, BMO Capital
Amount of Offering: N/A
Number of Shares Offered: 8 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Affimed is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company's product candidates are being developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells.
SEC Filings
News Headlines
